|
DYD B-11
|
|
|
CtdJhUoPrMrBie |
|
131 |
|
|
I can't get through at the moment http://fittor.fun/tehvids/ redhot
Prosensa has fared better than Belgium's Cardio3 BioSciences, which priced its initial public offering in Europe in early July at the bottom of its hoped-for range and took a further knock from questions over its research, which it said were unfounded. |
|
|
Christopher |
|
2020-04-18 22:18:06 |
|
|
|
|
|
|
|
|